ENSYSCE BIOSCIENCES, INC. — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/66a0de90-81a0-4628-bc29-cd6991ed681c/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-10.2M | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-013633 |
| FY 2024 | $-6.7M | 2024-01-01 – 2024-12-31 | evidence 0001493152-25-009703 |
| FY 2023 | $-10.7M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-009993 |
| FY 2022 | $-24.2M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-009844 |
| FY 2021 | $-19.9M | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-008438 |
| FY 2020 | $-1.6M | 2020-01-01 – 2020-12-31 | evidence 0001493152-22-008438 |
| FY 2019 | $-3.3M | 2019-01-01 – 2019-12-31 | evidence 0001213900-20-005867 |
| FY 2018 | $-959.2k | 2018-01-01 – 2018-12-31 | evidence 0001615774-19-003912 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ENSYSCE BIOSCIENCES, INC. — all facts · Revenue · Net Income